The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 4,106 | 109,000 | SH | Call | SOLE | 109,000 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 13,062 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 3,645 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 4,958 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 3,719 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 14,029 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,112 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 3,016 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 5,676 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 5,710 | 252,534 | SH | SOLE | 252,534 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 7,250 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 10,112 | 104,539 | SH | SOLE | 104,539 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 19,346 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
AXOVANT SCIENCES LTD | COM | G0750W104 | 688 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 2,620 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 8,022 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 4,781 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 9,561 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
CURRENCYSHS BRIT POUND STER | BRIT POUND STE | 23129S106 | 3,923 | 30,100 | SH | SOLE | 30,100 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 17,862 | 420,886 | SH | SOLE | 420,886 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 17,125 | 403,500 | SH | Put | SOLE | 403,500 | 0 | 0 | |
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 1,223 | 64,410 | SH | SOLE | 64,410 | 0 | 0 | ||
ENTELLUS MED INC | COM | 29363K105 | 10,365 | 561,510 | SH | SOLE | 561,510 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 1,296 | 53,500 | SH | SOLE | 53,500 | 0 | 0 | ||
GENMARK DIAGNOSTICS INC | COM | 372309104 | 9,149 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 7,763 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 5,075 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 6,793 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 27,218 | 1,946,946 | SH | SOLE | 1,946,946 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 4,086 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 10,125 | 324,400 | SH | SOLE | 324,400 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 9,363 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 2,031 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 5,804 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 7,004 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
IRIDEX CORP | COM | 462684101 | 1,869 | 199,519 | SH | SOLE | 199,519 | 0 | 0 | ||
JUNO THERAPEUTICS INC | COM | 48205A109 | 4,486 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 2,848 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 4,162 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 983 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 5,580 | 345,284 | SH | SOLE | 345,284 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 3,660 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 13,788 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 10,451 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 1,664 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
PATTERSON COMPANIES INC | COM | 703395103 | 6,184 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 2,001 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 2,001 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 7,784 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 924 | 187,450 | SH | SOLE | 187,450 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 3,431 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 2,794 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 9,345 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 4,536 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 7,133 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 30,300 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 9,460 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
VERSARTIS INC | COM | 92529L102 | 674 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 7,602 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 4,032 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 8,782 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 21,030 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 22,783 | 650,000 | SH | Put | SOLE | 650,000 | 0 | 0 |